cro.directory
← Home
GenoSafe logo

GenoSafe

Analytical CRO for innovative therapies

GenoSafe is an analytical CRO for gene and cell therapies, innovative vaccines and DNA/RNA-based products. It offers preclinical analytical testing, quality control method development for ATMPs, and clinical sample bioanalysis. Headquartered in Evry-Courcouronnes, France.

Phases

Services

Modalities

About this organization

GenoSafe is a contract research organization focused on the characterization and evaluation of innovative therapeutics. The company supports sponsors across research, preclinical studies, quality control, and clinical studies.

Fields of activity

  • Preclinical development: Development and validation of analytical methods, and analysis of samples for research or regulatory toxicity studies.
  • Quality control: Development, qualification and validation of methods to evaluate the quality, safety and efficacy of Advanced Therapy Medicinal Products (ATMPs).
  • Clinical development: Development, qualification and validation of methods for clinical sample analysis.

Scope

GenoSafe focuses on innovative therapeutics, including gene and cell therapies, innovative vaccines, and DNA/RNA-based products. The company states that its services are designed to comply with regulatory standards applicable to each aspect of pharmaceutical development.

Teams and labs

The company describes its teams and platforms as providing the expertise and quality needed for analytical work, with a dedicated contact assigned to each project.

Locations

  • Evry-Courcouronnes

    Evry-Courcouronnes · France

Similar profiles by shared services, phases, and indications.

Submit a verified review for this organization.

Markdown mirror: /companies/genosafe.md